Sterling Capital Management LLC Decreases Position in Colgate-Palmolive (CL)

Sterling Capital Management LLC trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL) by 15.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 16,122 shares of the company’s stock after selling 2,934 shares during the period. Sterling Capital Management LLC’s holdings in Colgate-Palmolive were worth $1,195,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in CL. Transamerica Financial Advisors Inc. boosted its position in Colgate-Palmolive by 0.3% in the 1st quarter. Transamerica Financial Advisors Inc. now owns 25,183 shares of the company’s stock valued at $1,844,000 after buying an additional 67 shares during the last quarter. Ronald Blue & Co. LLC boosted its position in Colgate-Palmolive by 1.1% in the 1st quarter. Ronald Blue & Co. LLC now owns 3,501 shares of the company’s stock valued at $256,000 after buying an additional 37 shares during the last quarter. USS Investment Management Ltd boosted its position in Colgate-Palmolive by 1.6% in the 1st quarter. USS Investment Management Ltd now owns 683,600 shares of the company’s stock valued at $50,036,000 after buying an additional 10,600 shares during the last quarter. Stifel Financial Corp boosted its position in Colgate-Palmolive by 0.8% in the 1st quarter. Stifel Financial Corp now owns 303,934 shares of the company’s stock valued at $22,250,000 after buying an additional 2,360 shares during the last quarter. Finally, ARS Investment Partners LLC boosted its position in Colgate-Palmolive by 0.5% in the 1st quarter. ARS Investment Partners LLC now owns 35,531 shares of the company’s stock valued at $2,601,000 after buying an additional 175 shares during the last quarter. 72.96% of the stock is owned by hedge funds and other institutional investors.

CL has been the subject of a number of analyst reports. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 price objective for the company in a research report on Monday, September 25th. SunTrust Banks raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their price objective for the company from $65.00 to $85.00 in a research report on Wednesday, October 11th. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. Royal Bank Of Canada reissued a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Finally, Jefferies Group reissued a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a research report on Thursday, September 28th. Two equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and four have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $76.04.

In other news, Director Stephen I. Sadove sold 20,780 shares of the company’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $70.52, for a total value of $1,465,405.60. Following the sale, the director now owns 36,268 shares in the company, valued at approximately $2,557,619.36. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Victoria L. Dolan sold 10,000 shares of the company’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $73.07, for a total transaction of $730,700.00. Following the completion of the sale, the insider now owns 60,528 shares in the company, valued at approximately $4,422,780.96. The disclosure for this sale can be found here. In the last 90 days, insiders sold 173,673 shares of company stock worth $12,629,293. Company insiders own 1.02% of the company’s stock.

Shares of Colgate-Palmolive (NYSE CL) opened at $73.32 on Friday. The stock has a market cap of $64,277.30, a PE ratio of 25.50, a PEG ratio of 3.35 and a beta of 0.81. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. Colgate-Palmolive has a 12 month low of $63.43 and a 12 month high of $77.27.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.73. The business had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.73 EPS. sell-side analysts forecast that Colgate-Palmolive will post 2.88 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd were paid a $0.40 dividend. The ex-dividend date was Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.18%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 61.78%.

ILLEGAL ACTIVITY NOTICE: This report was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.dispatchtribunal.com/2017/12/09/sterling-capital-management-llc-decreases-position-in-colgate-palmolive-cl.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply